Compare NXTC & NWTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXTC | NWTG |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6M | 7.1M |
| IPO Year | 2019 | N/A |
| Metric | NXTC | NWTG |
|---|---|---|
| Price | $11.30 | $1.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 53.3K | ★ 143.0K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,931,000.00 |
| Revenue This Year | N/A | $120.41 |
| Revenue Next Year | N/A | $70.24 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 178.24 |
| 52 Week Low | $2.69 | $0.82 |
| 52 Week High | $15.74 | $40.20 |
| Indicator | NXTC | NWTG |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 53.35 |
| Support Level | $10.80 | $1.62 |
| Resistance Level | $12.49 | $1.75 |
| Average True Range (ATR) | 1.34 | 0.17 |
| MACD | -0.27 | 0.02 |
| Stochastic Oscillator | 6.88 | 55.86 |
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.